Table 3.

Multivariate analysis of factors associated with inappropriate DOAC dosage

	P-value	Odds ratio	95% CI
Permanent AF	0.065	1.31	0.98–1.74
Male gender, n (%)	0.79	1.04	0.78–1.39
Age	<0.0001	1.07	1.05–1.09
HASBLED score	0.29	1.09	0.93–1.28
Apixaban	0.58	1.08	0.82–1.43
CHA2DS2VASc score	0.0056	1.17	1.05–1.31

AF, atrial fibrillation; CI, confidence interval; DOAC, direct oral anticoagulant.